- Home
- Publications
- Publication Search
- Publication Details
Title
Neuropsychiatric Effects of HIV Antiviral Medications
Authors
Keywords
Efavirenz, Nevirapine, Darunavir, Raltegravir, Maraviroc
Journal
DRUG SAFETY
Volume 39, Issue 10, Pages 945-957
Publisher
Springer Nature
Online
2016-08-17
DOI
10.1007/s40264-016-0440-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of Abacavir and Risk of Cardiovascular Disease Among HIV-Infected Individuals
- (2016) Julia L. Marcus et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data
- (2016) Ella T. Nkhoma et al. MEDICINE
- Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz
- (2016) Dhwanil A. Dalwadi et al. PHARMACOLOGICAL RESEARCH
- Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study
- (2015) Laura Dickinson et al. CLINICAL PHARMACOKINETICS
- Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment
- (2015) Khutso Mothapo et al. CNS & Neurological Disorders-Drug Targets
- Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study
- (2015) E Pedrol et al. HIV MEDICINE
- Efavirenz and the CNS: what we already know and questions that need to be answered
- (2015) Nadezda Apostolova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study
- (2015) Adriana Carvalhal et al. JOURNAL OF NEUROVIROLOGY
- Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients
- (2015) Qing Ma et al. JOURNAL OF NEUROVIROLOGY
- Rilpivirine and Depression
- (2015) David Freeman et al. PSYCHOSOMATICS
- Drug-induced Depression: a Case/Non Case Study in the French Pharmacovigilance Database
- (2015) Claire Lafay-Chebassier et al. THERAPIE
- Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient
- (2015) Marcel Lee et al. AIDS Research and Therapy
- The Cerebrospinal Fluid HIV Risk Score for Assessing Central Nervous System Activity in Persons With HIV
- (2014) E. R. Hammond et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide
- (2014) Katie R. Mollan et al. ANNALS OF INTERNAL MEDICINE
- Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility
- (2014) Massimiliano Fabbiani et al. ANTIVIRAL THERAPY
- Dolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients
- (2014) L. Curtis et al. HIV CLINICAL TRIALS
- Antiretroviral Treatment of Adult HIV Infection
- (2014) Huldrych F. Günthard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz
- (2014) A. Blas-Garcia et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Involvement of Nitric Oxide in the Mitochondrial Action of Efavirenz: A Differential Effect on Neurons and Glial Cells
- (2014) Nadezda Apostolova et al. JOURNAL OF INFECTIOUS DISEASES
- Neuronal Bioenergetics and Acute Mitochondrial Dysfunction: A Clue to Understanding the Central Nervous System Side Effects of Efavirenz
- (2014) Haryes A. Funes et al. JOURNAL OF INFECTIOUS DISEASES
- Neuropsychiatric Complications of Efavirenz Therapy: Suggestions for a New Research Paradigm
- (2014) Stefan Sütterlin et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- The relationship of CPE to HIV dementia: Slain by an ugly fact?
- (2014) J. R. Berger et al. NEUROLOGY
- Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions
- (2014) E. C. Caniglia et al. NEUROLOGY
- Efavirenz Promotes β-Secretase Expression and Increased Aβ1-40,42 via Oxidative Stress and Reduced Microglial Phagocytosis: Implications for HIV Associated Neurocognitive Disorders (HAND)
- (2014) Lecia A. M. Brown et al. PLoS One
- No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database
- (2014) Andrew A Napoli et al. Journal of the International AIDS Society
- Cytotoxic effect of efavirenz is selective against cancer cells and associated with the cannabinoid system
- (2013) Markus Hecht et al. AIDS
- Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
- (2013) Matteo Vassallo et al. AIDS
- 8-Hydroxy-efavirenz, the Primary Metabolite of the Antiretroviral Drug Efavirenz, Stimulates the Glycolytic Flux in Cultured Rat Astrocytes
- (2013) Maria Brandmann et al. NEUROCHEMICAL RESEARCH
- The HIV Antiretroviral Drug Efavirenz has LSD-Like Properties
- (2013) Michael B Gatch et al. NEUROPSYCHOPHARMACOLOGY
- Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score
- (2012) Y Kahouadji et al. HIV MEDICINE
- Severe insomnia related to high concentrations of raltegravir
- (2011) Céline Eiden et al. AIDS
- The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
- (2011) Magnus Gisslén et al. BMC INFECTIOUS DISEASES
- Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research
- (2011) Lucette A Cysique et al. BMC Neurology
- Long-Term Safety from the Raltegravir Clinical Development Program
- (2011) Hedy Teppler et al. CURRENT HIV RESEARCH
- Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
- (2011) Jean-Michel Molina et al. LANCET
- Survival after neuroAIDS: Association with antiretroviral CNS Penetration-Effectiveness score
- (2011) E. Lanoy et al. NEUROLOGY
- Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
- (2011) N. Ciccarelli et al. NEUROLOGY
- Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
- (2010) Marlene Smurzynski et al. AIDS
- A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine
- (2010) Laura Waters et al. AIDS
- Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms
- (2010) Luiz F. Ferrari et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Long-Term Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals (ACTG 5097s)
- (2010) David B. Clifford et al. HIV CLINICAL TRIALS
- Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies
- (2010) Brian Dean INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- African Mitochondrial DNA Subhaplogroups and Peripheral Neuropathy during Antiretroviral Therapy
- (2010) Jeffrey A. Canter et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
- (2010) Robert K. Heaton et al. JOURNAL OF NEUROVIROLOGY
- Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients
- (2010) Verena Gounden et al. AIDS Research and Therapy
- Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial
- (2009) Anton L Pozniak et al. AIDS
- Exacerbation of depression associated with starting raltegravir: a report of four cases
- (2008) Marianne Harris et al. AIDS
- Cytokine Genotype Suggests a Role for Inflammation in Nucleoside Analog-Associated Sensory Neuropathy (NRTI-SN) and Predicts an Individual's NRTI-SN Risk
- (2008) Catherine L. Cherry et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy
- (2008) Ronald J. Ellis et al. ANNALS OF NEUROLOGY
- Mechanisms of Zidovudine-Induced Mitochondrial Toxicity and Myopathy
- (2008) Erin R. Scruggs et al. PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started